Successful Bosutinib Experience in an Elderly Acute Lymphoblastic Leukemia Patient with Suspected Central Nervous System Involvement Transformed from Chronic Myeloid Leukemia.

about

Bosutinib in chronic myeloid leukemia: patient selection and perspectives.

P2860

Q52562694-416156F7-186F-4578-83C0-619EF433E0C6

P2860

Successful Bosutinib Experience in an Elderly Acute Lymphoblastic Leukemia Patient with Suspected Central Nervous System Involvement Transformed from Chronic Myeloid Leukemia.

Item

http://www.wikidata.org/entity/Q40178701

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Successful Bosutinib Experienc ...... from Chronic Myeloid Leukemia.

@en

type

Item

label

Successful Bosutinib Experienc ...... from Chronic Myeloid Leukemia.

@en

prefLabel

Successful Bosutinib Experienc ...... from Chronic Myeloid Leukemia.

@en

P1476

Successful Bosutinib Experienc ...... from Chronic Myeloid Leukemia.

@en

P2093

Elif Ozyurek

http://www.w3.org/2001/XMLSchema#string

Erden Atilla

http://www.w3.org/2001/XMLSchema#string

Gunhan Gurman

http://www.w3.org/2001/XMLSchema#string

Ilhan Erden

http://www.w3.org/2001/XMLSchema#string

Pinar Ataca

http://www.w3.org/2001/XMLSchema#string

P2860

An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.

Central nervous system involvement in adult acute lymphocytic leukemia.

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib

Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial.

Imatinib mesylate--a new oral targeted therapy.

Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.

In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells.

Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors

Short-term repopulating cells with myeloid potential in human mobilized peripheral blood do not have a side population (SP) phenotype.

A disease risk index for patients undergoing allogeneic stem cell transplantation.

P304

689423

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/689423

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26697241

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

P932

4678072

http://www.w3.org/2001/XMLSchema#string

Successful Bosutinib Experience in an Elderly Acute Lymphoblastic Leukemia Patient with Suspected Central Nervous System Involvement Transformed from Chronic Myeloid Leukemia.

about

P2860

P2860

Successful Bosutinib Experience in an Elderly Acute Lymphoblastic Leukemia Patient with Suspected Central Nervous System Involvement Transformed from Chronic Myeloid Leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932